Niacinamide, the form used in compounded tirzepatide, does not cause the same degree of insulin resistance as niacin, but high doses can still affect glucose metabolism
6 The phase 2 monotherapy dose-finding trial by Lau and colleagues established that once-weekly cagrilintide up to 4.5 mg produced dose-dependent weight loss about 10.8% at the top dose over 26 weeks with a gastrointestinal side-effect profile (nausea and related symptoms) that is the clinical fingerprint of a gut-slowing, satiating mechanism
If substitution is allowed in your treatment plan, compare bupropion XL 150 mg with Wellbutrin XL 150 mg, and bupropion XL 300 mg with Wellbutrin XL 300 mg, when those strengths are shown
When it comes to wellness and weight management, many people focus only on diet and exercise
A research peptide COA only helps if you actually read it in the right order
These off-target effects explain some of PT-141s side effect profile (discussed below)